PortfoliosLab logoPortfoliosLab logo
Marpai, Inc. (MRAI)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US5713541093
CUSIP
571354109
IPO Date
Oct 27, 2021

Highlights

EPS (TTM)
-$0.74
Total Revenue (TTM)
$20.70M
Gross Profit (TTM)
$6.36M
EBITDA (TTM)
-$11.16M
Year Range
$0.28 - $1.78
Target Price
$6.00
ROA (TTM)
-110.88%
ROE (TTM)
37.13%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Marpai, Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Marpai, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Marpai, Inc. (MRAI) has returned -54.04% so far this year and -71.57% over the past 12 months.


Marpai, Inc.

1D
-0.07%
1M
-48.31%
YTD
-54.04%
6M
-78.68%
1Y
-71.57%
3Y*
-58.29%
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Oct 27, 2021, MRAI's average daily return is +0.06%, while the average monthly return is +1.89%. At this rate, your investment would double in approximately 3.1 years.

Historically, 44% of months were positive and 56% were negative. The best month was Nov 2023 with a return of +412.2%, while the worst month was May 2024 at -68.5%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 7 months.

On a daily basis, MRAI closed higher 45% of trading days. The best single day was Apr 13, 2023 with a return of +90.3%, while the worst single day was May 28, 2024 at -53.6%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202624.93%-28.83%-48.31%-54.04%
20255.26%-9.00%12.09%-1.96%39.50%-3.23%-2.96%7.63%-3.55%6.62%-31.03%-36.90%-33.58%
2024-30.29%17.21%70.63%-16.80%-68.45%6.16%-23.51%5.75%0.91%69.37%70.21%-40.63%-45.71%
202327.68%5.52%2.99%-34.62%9.89%-40.43%4.09%-50.56%-24.89%-39.15%412.18%-15.05%-39.24%
2022-47.03%-13.79%-10.00%-11.11%-23.75%-20.74%-16.37%16.08%10.79%-15.38%10.53%-25.98%-83.56%
202117.89%-31.43%14.06%-7.79%

Benchmark Metrics

Marpai, Inc. has an annualized alpha of 3.07%, beta of 1.18, and R² of 0.02 versus S&P 500 Index. Calculated based on daily prices since October 28, 2021.

  • This stock participated in 250.00% of S&P 500 Index downside but only 33.46% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.02 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
3.07%
Beta
1.18
0.02
Upside Capture
33.46%
Downside Capture
250.00%

Return for Risk

Risk / Return Rank

MRAI ranks 12 for risk / return — in the bottom 12% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


MRAI Risk / Return Rank: 1212
Overall Rank
MRAI Sharpe Ratio Rank: 1515
Sharpe Ratio Rank
MRAI Sortino Ratio Rank: 1717
Sortino Ratio Rank
MRAI Omega Ratio Rank: 1818
Omega Ratio Rank
MRAI Calmar Ratio Rank: 99
Calmar Ratio Rank
MRAI Martin Ratio Rank: 33
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Marpai, Inc. (MRAI) and compare them to a chosen benchmark (S&P 500 Index).


MRAIBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.59

0.90

-1.49

Sortino ratio

Return per unit of downside risk

-0.57

1.39

-1.95

Omega ratio

Gain probability vs. loss probability

0.93

1.21

-0.28

Calmar ratio

Return relative to maximum drawdown

-0.86

1.40

-2.26

Martin ratio

Return relative to average drawdown

-1.82

6.61

-8.43

Explore MRAI risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Marpai, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Marpai, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Marpai, Inc. was 98.77%, occurring on Mar 26, 2026. The portfolio has not yet recovered.

The current Marpai, Inc. drawdown is 98.73%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.77%Oct 29, 20211105Mar 26, 2026

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Marpai, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Marpai, Inc. is priced in the market compared to other companies in the Healthcare Plans industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for MRAI relative to other companies in the Healthcare Plans industry. Currently, MRAI has a P/S ratio of 0.2. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items